Both in Pharmaceuticals
Evolus vs Faeth Therapeutics
Over the past year EOLS returned −6.3% and FTH returned −50.1%; their daily moves had a correlation of 0.41.
EOLS −6.3% FTH −50.1%Growth of $1, one year, split-adjusted
| Metric | EOLS | FTH |
|---|---|---|
| Price | $7.35 | $18.69 |
| Market cap | $485.5M | $483.0M |
| Today | −2.26% | −0.32% |
| 1 month | −4.4% | −33.9% |
| 6 months | +37.9% | — |
| Year to date | +10.5% | — |
| 1 year | +7.1% | — |
| Revenue growth (YoY) | +21.2% | — |
| Gross margin | 68.0% | — |
| Net margin | −9.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.5× | — |
| Net cash | -$141.9M | $186.4M |
| Dividend yield | — | — |
| Volatility (60d) | 52.4% | — |
| Short % of float | 12.2% | 16.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).